X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://ir.springworkstx.com/news-releases/news-release-details/springworks-therapeutics-announces-european-medicines-agency
https://www.globenewswire.com//news-release/2024/02/29/2837999/0/en/SpringWorks-Therapeutics-Announces-European-Medicines-Agency-Validation-for-Marketing-Authorization-Application-of-Nirogacestat-for-the-Treatment-of-Adults-with-Desmoid-Tumors.html
https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-type-non-cancerous-tumors#:~:text=Today%2C%20the%20U.S.%20Food%20and,tumors%20who%20require%20systemic%20treatment
https://www.reuters.com/business/healthcare-pharmaceuticals/springworks-non-cancerous-tumor-drug-be-priced-29000-per-month-us-2023-11-28/
https://www.globenewswire.com//news-release/2023/11/01/2770919/0/en/SpringWorks-Therapeutics-Announces-Presentation-of-Additional-Data-from-Phase-3-DeFi-Trial-of-Nirogacestat-in-Adults-with-Desmoid-Tumors-at-the-2023-CTOS-Annual-Meeting.html
https://www.globenewswire.com/news-release/2023/05/25/2676776/0/en/SpringWorks-Therapeutics-Announces-Presentation-of-Additional-Data-from-Phase-3-DeFi-Trial-of-Nirogacestat-in-Adults-with-Desmoid-Tumors-at-the-2023-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2023/05/11/2667102/0/en/SpringWorks-Therapeutics-Announces-Clinical-Data-Presentations-of-Nirogacestat-in-Combination-with-BCMA-Directed-Therapies-at-the-European-Hematology-Association-2023-Congress.html
https://ir.springworkstx.com/news-releases/news-release-details/springworks-therapeutics-announces-new-england-journal-medicine
https://endpts.com/pfizer-spinout-springworks-gets-fda-priority-review-for-lead-drug/
https://www.biospace.com/article/releases/springworks-therapeutics-completes-submission-of-new-drug-application-to-the-fda-for-nirogacestat-for-the-treatment-of-adults-with-desmoid-tumors-/
https://www.globenewswire.com/news-release/2022/09/29/2524977/0/en/SpringWorks-Therapeutics-Announces-Dosing-of-First-Patient-in-Phase-2-Trial-Evaluating-Nirogacestat-in-Patients-with-Ovarian-Granulosa-Cell-Tumors.html
https://www.globenewswire.com/news-release/2022/09/10/2513558/0/en/SpringWorks-Therapeutics-Announces-Data-from-Phase-3-DeFi-Trial-Evaluating-Nirogacestat-in-Adult-Patients-with-Progressing-Desmoid-Tumors-at-the-European-Society-for-Medical-Oncolo.html
https://www.globenewswire.com/news-release/2022/09/07/2511721/0/en/SpringWorks-Announces-Expansion-of-Global-Non-Exclusive-Collaboration-with-GSK-for-Nirogacestat-in-Combination-with-Blenrep-in-Patients-with-Multiple-Myeloma.html
https://www.globenewswire.com/news-release/2022/08/19/2501439/0/en/SpringWorks-Therapeutics-Announces-Late-Breaking-Oral-Presentation-of-Phase-3-DeFi-Data-at-the-European-Society-for-Medical-Oncology-ESMO-Congress-2022.html
https://www.fiercebiotech.com/biotech/boing-springworks-stock-jumps-phase-3-tumor-trial-hits-goal
https://www.globenewswire.com/news-release/2022/04/19/2424196/0/en/SpringWorks-Therapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-Regeneron-to-Evaluate-Nirogacestat-in-Combination-with-REGN5458-in-Patients-with-Relapsed-.html
https://www.globenewswire.com/news-release/2021/12/10/2349945/0/en/SpringWorks-Therapeutics-Announces-Clinical-Collaboration-with-AbbVie-to-Evaluate-Nirogacestat-in-Combination-with-ABBV-383-in-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma.html
https://ir.springworkstx.com/news-releases/news-release-details/springworks-therapeutics-announces-dosing-first-patient-phase
https://www.globenewswire.com/news-release/2021/08/30/2288138/0/en/SpringWorks-Therapeutics-Enters-into-Research-Collaboration-with-Leading-Cancer-Institute-to-Further-Evaluate-Nirogacestat-as-a-BCMA-Potentiator-in-Multiple-Myeloma.html
https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-receives-ind-clearance-us-food-and-drug
https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-receives-ind-clearance-us-food-and-drug
https://www.globenewswire.com/news-release/2020/09/21/2096382/0/en/Precision-BioSciences-and-SpringWorks-Therapeutics-Announce-Clinical-Collaboration-to-Evaluate-PBCAR269A-in-Combination-with-Nirogacestat-in-Patients-with-Relapsed-or-Refractory-Mu.html
Market Place
Share 
